Accenture PLC (NYSE:ACN) is a quality stock that has outperformed the market and will continue to do so in the future. The company delivers value by leveraging industry knowledge and technical expertise in the five segments that they serve: Communications – Media & Technology, Financial Services, Health & Public Service, Products, and Resources. The majority of their revenue is driven from consulting work, but they are also a large player in outsourcing. Their solid value proposition in outsourcing has performed well recently, winning large deals from Pfizer (NYSE:PFE), Merck (NYSE:MRK), GlaxoSmithKline (NYSE:GSK), and Eli Lily (NYSE:LLY).
Geographically, Accenture has slightly more revenue outside of the US compared to in the US; however, in the last year, the US market was double the growth of international markets.